FDA officials warn certain recalled Fresenius hemodialysis machines can leak toxic compounds into the bloodstream for up to a month after the devices are first put into service, posing serious and deadly risks to patients.
Drug maker agreed to settle all Nexium, Prilosec lawsuits brought by former users diagnosed with kidney failure, kidney disease or other kidney injuries.
Decreased kidney function makes it harder for the body to filter out digoxin, which could cause the heart drug to a buildup in toxicity, researchers warn.
A series of three bellwether trials involving kidney damage lawsuits over Nexium, Prilosec and other heartburn drugs will go before juries in October 2023, November 2023 and January 2024
Two additional bellwether trials are scheduled to begin in July and September 2023, which will help gauge how juries may respond to evidence about the risk of kidney damage from Nexium, Prilosec and other PPIs
Bellwether jury trial for the first Nexium kidney damage lawsuit was originally scheduled to begin on November 14, 2022. However, the start has been postponed as parties meet to discuss settlement
A series of settlement conferences will be held with drug makers in September and October 2022, weeks before the first Nexium lawsuit is set to go before a jury involving kidney disease caused by the heartburn drug
Lawsuit over chronic kidney disease from Nexium will be the first of more than 13,500 claims to go before a jury when trial begins in November 2022
First case to go to trial involves a Nexium lawsuit filed over a kidney disease diagnosis, which is expected to be followed by additional bellwether trials in March 2023 and April 2023
Large groups of Nexium lawsuits, Prilosec lawsuits and other claims involving kidney damage following use of popular heartburn drugs will be selected each quarter, and prepared for trial
